{
  "created_at": "Fri Apr 16 21:12:49 +0000 2021",
  "id_str": "1383144188318003210",
  "full_text": "Despite the apparently poor results in stopping infections, the Sinovac vaccine appears to offer remarkably good protection against severe disease and death https://t.co/WamOKFPPh0",
  "display_text_range": [
    0,
    180
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/WamOKFPPh0",
        "expanded_url": "https://econ.st/3aaSzRu",
        "display_url": "econ.st/3aaSzRu",
        "indices": [
          157,
          180
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 29,
  "favorite_count": 93,
  "possibly_sensitive": false,
  "original_created_at": "Fri Apr 16 19:44:06 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "感染を阻止する結果が明らかに悪いにもかかわらず、シノバッ ク・ワクチンは重篤な病気や死亡に対して非常に優れた保護を提供しているようです https://t.co/WamOKFPPh0"
    },
    {
      "locale": "zh",
      "full_text": "尽管在阻止感染方面的效果明显不佳，但华诺威疫苗似乎对严重疾病和死亡提供了非常好的保护https://t.co/WamOKFPPh0。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "儘管在阻止感染方面的效果明顯不佳，但華諾威疫苗似乎對嚴重疾病和死亡提供了非常好的保護https://t.co/WamOKFPPh0。"
    }
  ]
}